Refurbished Medical Devices Market

The global refurbished medical devices market is expected to be valued at US$ 20.90 Billion in 2026 and is projected to reach US$ 40.21 Billion by 2033, growing at a CAGR of 9.8% between 2026 and 2033. The World Health Organization's sustained push to close diagnostic equipment gaps in low- and middle-income countries operationalized through its Global Initiative on Health Technologies is the primary structural catalyst, directing institutional procurement toward certified pre-owned alternatives to close access gaps without equivalent capital outlay. Corroborating this trajectory, GE HealthCare reported that refurbished imaging systems accounted for a measurably expanding share of its installed-base transactions across emerging markets, signalling durable demand well beyond opportunistic budget cycles. Accelerating healthcare infrastructure investment across cost-constrained public health systems is structurally repositioning refurbished medical devices from a procurement afterthought to a primary capital equipment strategy.

• North America's US$ 8.36 Billion installed-market position reflects structural advantages group purchasing Organisation scale, mature device-history documentation standards, and deep OEM service networks that will sustain regional leadership even as Asia Pacific compresses the share gap through CAGR of 11.1% over the forecast period.
• Medical Imaging Equipment's 40.0% market share is structurally defended by the high unit economics of CT, MRI, and digital radiography systems, where a 40–60% refurbishment price discount translates into seven-figure savings per procurement cycle, making cost avoidance arguments decisive in hospital capital committee approvals.
• OEM-Certified Refurbishers commanding 64.0% of provider-segment value reflects institutional risk management priorities hospital boards and group purchasing organizations treat OEM certification as non-negotiable proof of clinical performance consistency, a procurement norm that will prove durable even as independent operators improve their quality documentation.
• Operating Room & Surgical Equipment is accelerating fastest within the product category because ambulatory surgery center proliferation driven by CMS site-neutral payment policies in the United States is creating a large new buyer cohort requiring full theatre fit-outs at independent-facility economics, opening a market segment historically dominated by acute-care hospital procurement.
• AI-augmented refurbishment embedding diagnostic software into certified pre-owned imaging platforms represents the highest-margin strategic opportunity through 2033, with Fujifilm Healthcare and specialized independent refurbishes best positioned to capture it, provided regulatory bodies formalize software-overlay classification under existing device refurbishment frameworks.

• Regulatory Standardisation of Refurbishment Protocols Enhancing Buyer Confidence

Formalised refurbishment standards are removing the clinical risk perception that historically suppressed institutional adoption, unlocking procurement pipelines that previously defaulted to new-equipment vendors.

The U.S. Food and Drug Administration's guidance on remanufacturing and refurbishment reinforced by the European Commission's Medical Device Regulation (MDR) 2017/745 has materially raised the compliance floor, and Philips Healthcare completed recertification of its refurbished imaging portfolio to MDR standards in 2024.

As regulatory harmonization deepens across ASEAN and Gulf Cooperation Council member states, certified refurbished devices will achieve procurement parity with new equipment in an expanding set of tender markets.

• Fragmented Quality Assurance Standards Suppressing Cross-Border Trade

Divergent national refurbishment certification requirements impose significant transaction friction, raising compliance costs and extending import lead times for cross-border device flows.

The U.S. FDA and EU MDR frameworks impose parallel but non-reciprocal conformity obligations, adding an estimated 15–25% to landed compliance costs for devices moving between these jurisdictions.

Independent refurbishes with narrower compliance infrastructure bear this burden disproportionately, effectively ceding international markets to OEM-certified operators with established regulatory teams.

• Digital Integration and AI-Augmented Diagnostics Within Refurbished Imaging Platforms

Technology integrators and specialized refurbishers can unlock a high-margin opportunity by embedding AI-assisted diagnostic software into refurbished imaging platforms, converting legacy hardware into analytically competitive systems.

Nanox and Fujifilm Healthcare have separately demonstrated, between 2023 and 2025, that software overlays can materially extend the clinical utility of refurbished radiography and CT platforms without full hardware replacement cycles.

Independent refurbishes with strong software partnerships are best positioned to capture this margin layer, provided regulatory bodies formalize software-as-a-refurbishment-component classification frameworks.

• Product Type Analysis

Medical imaging equipment accounts for 40.0% of the refurbished medical devices market in 2026, equivalent to US$ 8.36 Billion.

This segment leads because imaging systems CT scanners, MRI units, and digital X-ray platforms represent the single largest capital expenditure item in hospital budgets, making the cost differential between new and refurbished units most economically significant for procurement committees.

Community health centres and rural district hospitals across the United States routinely acquire refurbished GE HealthCare or Canon Medical Systems CT units to establish diagnostic capability that new-equipment pricing would otherwise preclude.

Academic medical centres similarly deploy refurbished MRI systems in research annexes, preserving primary-budget capital for frontier imaging modalities.

Operating Room & Surgical Equipment is the fastest-growing segment, driven by the accelerating backlog in elective surgical procedures following the COVID-19 disruption and the consequent pressure on health systems to expand theatre capacity rapidly. Avante Health Solutions broadened its certified surgical equipment catalogue in 2024, specifically targeting ambulatory surgery centres seeking to add laparoscopic towers and electrosurgical units without multi-year new-equipment procurement cycles.

• Refurbishment Provider Analysis

OEM-certified refurbishes account for 64.0% of the refurbished medical devices market in 2026, equivalent to US$ 13.38 Billion.

Hospital procurement officers and group purchasing organisations systematically favour OEM-certified channels because full device traceability, original-specification parts, and continued warranty coverage reduce the clinical and regulatory liability that procurement committees must defend to Joint Commission auditors and risk management teams.

Large integrated delivery networks in North America, for instance, specify OEM certification as a mandatory tender condition when sourcing refurbished imaging systems, effectively ring-fencing the majority of institutional volume for manufacturers such as Philips Healthcare and Siemens Healthineers.

Independent & In-House Refurbishers represent the fastest-growing provider segment, propelled by cost-sensitive mid-market hospitals and public health systems seeking alternatives to OEM price premiums. Block Imaging International expanded its independent refurbishment and parts-harvesting operations in 2023–2024, capitalising on health system procurement officers who require certified-quality devices at independent-market pricing, particularly across cardiovascular and patient monitoring categories where OEM programme coverage remains thinner.

• North America Refurbished Medical Devices Market Trends and Insights

North America accounts for 40.0% of the refurbished medical devices market in 2026, representing US$ 8.36 Billion.

The region's dominance reflects a confluence of mature group purchasing organisation infrastructure, high per-capita healthcare expenditure, and a large installed base of ageing capital equipment due for cost-optimised replacement.

The U.S. Inflation Reduction Act's downstream pressure on hospital operating costs has reinforced budget discipline, accelerating refurbished device procurement across integrated delivery networks.

North America will maintain regional leadership through 2033, though its share will compress modestly as Asia Pacific and Middle East markets scale.

U.S. Refurbished Medical Devices Market Size

The U.S. refurbished medical devices market represents 88.0% of the North America regional market in 2026, equivalent to US$ 7.36 Billion.

Demand is anchored by the country's extensive network of rural critical access hospitals over 1,700 federally designated facilities where refurbished imaging and monitoring equipment enables clinical capability within constrained operating budgets.

Sustained reimbursement pressure from CMS will keep refurbished devices central to capital planning cycles well into the forecast period.

Canada Refurbished Medical Devices Market Size

The Canada refurbished medical devices market represents 12.0% of the North America regional market in 2026, equivalent to US$ 1.00 Billion.

Provincial health authorities operating under Canada Health Act funding constraints are progressively incorporating refurbished imaging systems into infrastructure renewal plans, particularly across Ontario and British Columbia where diagnostic waitlist pressures are acute.

Expansion of Health Canada's medical device licensing pathways for certified refurbished equipment will validate procurement at the institutional level through the forecast period.

• Asia Pacific Refurbished Medical Devices Market Trends and Insights

Asia Pacific accounts for 27.0% of the refurbished medical devices market in 2026, representing US$ 5.64 Billion, and is the fastest-growing region at an estimated CAGR of 11.1% through 2033.

The primary acceleration force is the simultaneous scaling of public hospital infrastructure investment across China, India, and Southeast Asian economies, where governments are expanding diagnostic capacity faster than new-equipment budgets allow.

India's Ayushman Bharat Digital Mission and China's Healthy China 2030 initiative together represent the most substantial public health infrastructure commitments currently in execution. Both programmes are structurally accommodating of certified refurbished equipment as a cost-efficient deployment mechanism.

China Refurbished Medical Devices Market Size

The China refurbished medical devices market represents 35.0% of the Asia Pacific regional market in 2026, equivalent to US$ 1.98 Billion.

China's National Medical Products Administration has progressively clarified refurbished device import and domestic refurbishment standards, reducing regulatory uncertainty that previously constrained institutional procurement.

County-level hospitals scaling under the Healthy China 2030 framework represent the most immediate high-volume demand cohort for refurbished CT and ultrasound platforms.

India Refurbished Medical Devices Market Size

The India refurbished medical devices market represents 17.0% of the Asia Pacific regional market in 2026, equivalent to US$ 0.96 Billion.

The Medical Devices Rules, 2017, amended progressively through 2023, have clarified the regulatory pathway for refurbished device importation, reducing customs uncertainty and enabling more structured procurement by private hospital chains such as Apollo Hospitals and Fortis Healthcare.

As domestic refurbishment capacity grows alongside the Production-Linked Incentive scheme for medical devices, India will transition from primarily import-dependent to a mixed-source refurbished equipment market by the early 2030s.

The global refurbished medical devices market is moderately consolidated at the OEM-certified tier, with GE HealthCare, Philips Healthcare, and Siemens Healthineers collectively commanding the majority of certified refurbished imaging volume through proprietary programmes that leverage original parts supply chains and service networks.

Competition intensifies at the independent refurbishment tier, where Block Imaging International and Avante Health Solutions compete on price flexibility, parts sourcing depth, and turnaround speed. The dominant strategic theme across both tiers is traceability infrastructure winners are investing in digital device-history records and remote diagnostics to satisfy escalating regulatory audit requirements. Nanox, pursuing a lease-based refurbished imaging deployment model, represents the most structurally disruptive entrant, challenging conventional capital-sale assumptions across the diagnostics segment.

• Agito Medical
• Amber Diagnostics
• Avante Health Solutions
• Block Imaging International
• Canon Medical Systems
• Fair Medical Co., Ltd
• Fujifilm Healthcare
• GE HealthCare
• Henry Schein Medical
• Hitachi Healthcare Systems
• Integrity Medical Systems
• Philips Healthcare
• Siemens Healthineers
• Nanox
• Soma Technology
• Meditek
• USOC Medical

By Product Type

• Medical Imaging Equipment
• Operating Room & Surgical Equipment
• Patient Monitoring Devices
• Cardiovascular & Cardiology Equipment
• Neurology Equipment

By Refurbishment Provider

• OEM-Certified Refurbishers
• Independent & In-House Refurbishers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa